Biocept Inc (NASDAQ:BIOC) said that it has started offering a single test that can detect and distinguish between SARS-CoV-2 and influenza, helping patients and caregivers determine appropriate treatment decisions.  This new assay expands the company's coronavirus (COVID-19) testing program, which began in June 2020 a
Full Story >>
Vote
+17